How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in Q3 2021?

82 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock for Q3 2021. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

Q: What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock used to aggregate holder disclosures.

CUSIP: 75629V104

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Class A Common Stock
Shares outstanding: 514,715,255
Total 13F shares: 54,909,739
Share change: +7,941,005
Total reported value: $1,262,978,377
Put/Call ratio: 29%
Price per share: $23.01
Number of holders: 82
Value change: +$181,552,159
Number of buys: 58
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP 75629V104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAILLIE GIFFORD & CO	13F	Company	3.6%	18,521,000	$676,017,000	—	30 Jun 2021	13F
Laurion Capital Management LP	13F	Company	0.75%	3,858,617	$140,839,000	—	30 Jun 2021	13F
VANGUARD GROUP INC	13F	Company	0.52%	2,683,107	$97,934,000	—	30 Jun 2021	13F
ARK Investment Management LLC	13F	Company	0.46%	2,378,675	$86,822,000	—	30 Jun 2021	13F
FMR LLC	13F	Company	0.43%	2,211,601	$80,724,000	—	30 Jun 2021	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.29%	1,509,254	$55,088,000	—	30 Jun 2021	13F
CREDIT SUISSE AG/	13F	Company	0.28%	1,449,585	$52,909,000	—	30 Jun 2021	13F
BlackRock Finance, Inc.	13F	Company	0.28%	1,444,078	$52,709,000	—	30 Jun 2021	13F
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC	13F	Company	0.27%	1,388,889	$50,694,446	—	30 Jun 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.25%	1,299,922	$47,447,000	—	30 Jun 2021	13F
Comprehensive Financial Management LLC	13F	Company	0.22%	1,109,395	$40,493,000	—	30 Jun 2021	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.19%	975,929	$35,621,000	—	30 Jun 2021	13F
Samsara BioCapital, LLC	13F	Company	0.15%	775,583	$28,309,000	—	30 Jun 2021	13F
CRV, LLC	13F	Company	0.14%	733,986	$26,790,000	—	30 Jun 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.11%	583,085	$21,283,000	—	30 Jun 2021	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	0.11%	550,000	$20,075,000	—	30 Jun 2021	13F
Casdin Capital, LLC	13F	Company	0.11%	548,156	$20,008,000	—	30 Jun 2021	13F
NORGES BANK	13F	Company	0.1%	500,000	$18,250,000	—	30 Jun 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	496,949	$18,138,000	—	30 Jun 2021	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.09%	472,552	$17,248,000	—	30 Jun 2021	13F
BAMCO INC /NY/	13F	Company	0.08%	425,000	$15,512,000	—	30 Jun 2021	13F
PointState Capital LP	13F	Company	0.08%	412,972	$15,073,000	—	30 Jun 2021	13F
STATE STREET CORP	13F	Company	0.07%	377,432	$13,776,000	—	30 Jun 2021	13F
Pentwater Capital Management LP	13F	Company	0.05%	252,500	$9,216,000	—	30 Jun 2021	13F
NORTHERN TRUST CORP	13F	Company	0.05%	242,376	$8,846,000	—	30 Jun 2021	13F
Amova Asset Management Americas, Inc.	13F	Company	0.05%	235,846	$8,613,000	—	30 Jun 2021	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.04%	213,608	$7,797,000	—	30 Jun 2021	13F
Artal Group S.A.	13F	Company	0.04%	200,000	$7,300,000	—	30 Jun 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.03%	164,881	$6,019,000	—	30 Jun 2021	13F
Ratan Capital Management LP	13F	Company	0.02%	110,000	$4,015,000	—	30 Jun 2021	13F
HBK INVESTMENTS L P	13F	Company	0.02%	100,000	$3,650,000	—	30 Jun 2021	13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY	13F	Company	0.02%	84,776	$3,094,000	—	30 Jun 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.02%	78,730	$2,873,000	—	30 Jun 2021	13F
Bank of New York Mellon Corp	13F	Company	0.01%	73,394	$2,679,000	—	30 Jun 2021	13F
ALLEN OPERATIONS LLC	13F	Company	0.01%	68,104	$2,486,000	—	30 Jun 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	50,646	$1,849,000	—	30 Jun 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	40,634	$1,233,000	—	30 Jun 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.01%	31,533	$1,149,000	—	30 Jun 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.01%	29,154	$1,064,000	—	30 Jun 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.01%	27,300	$996,000	—	30 Jun 2021	13F
RHUMBLINE ADVISERS	13F	Company	0%	20,818	$760,000	—	30 Jun 2021	13F
Bellevue Group AG	13F	Company	0%	20,000	$730,000	—	30 Jun 2021	13F
JPMORGAN CHASE & CO	13F	Company	0%	19,992	$730,000	—	30 Jun 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	18,100	$661,000	—	30 Jun 2021	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0%	15,000	$548,000	—	30 Jun 2021	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	14,240	$520,000	—	30 Jun 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0%	13,600	$496,000	—	30 Jun 2021	13F
CNA FINANCIAL CORP	13F	Company	0%	13,432	$490,000	—	30 Jun 2021	13F
DEUTSCHE BANK AG\	13F	Company	0%	13,122	$479,000	—	30 Jun 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	11,839	$432,000	—	30 Jun 2021	13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q3 2021

As of 30 Sep 2021, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,909,739 shares. The largest 10 holders included BAILLIE GIFFORD & CO, Laurion Capital Management LP, VANGUARD GROUP INC, ARK Investment Management LLC, FMR LLC, BlackRock Inc., STATE STREET CORP, ALLIANCEBERNSTEIN L.P., HARVARD MANAGEMENT CO INC, and CREDIT SUISSE AG/. This page lists 82 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

Q3 2021 holders

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 Value $	Q3 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.